Prometheus Laboratories Launches MASH Precis™, a Purpose-Built Non-Invasive Test Designed to Support Evolving MASH Pathways
News & Events Prometheus Laboratories [...]
About Chrystal Johnson
This author has not yet filled in any details.So far Chrystal Johnson has created 12 blog entries.
Celltrion USA and Prometheus Laboratories Inc. Announce Sponsored Testing Collaboration on Anser® IFX for ZYMFENTRA® (infliximab-dyyb)
News & Events Celltrion USA [...]
Prometheus Signals Near Term Development of Next Generation Noninvasive Test for MASH Patients at DDW® 2026
News & Events Prometheus Signals [...]
Prometheus Laboratories Showcases Drug Clearance as a Foundation for Precision Guided Biologic Dosing in IBD at DDW® 2026
News & Events Prometheus Laboratories [...]
Prometheus Laboratories Launches IBD Precis™ Featuring Breakthrough Colonic Markers to Transform UC and CD Assessment
News & Events Prometheus Laboratories [...]
Prometheus Laboratories Announces Collaboration with Celltrion for Anser® Testing
News & Events Prometheus Laboratories [...]
Prometheus Laboratories Expands Precision-Guided Dosing Tests with the Launch of PredictrPK® VDZ and UST
News & Events Prometheus Laboratories [...]
PredictrPK® ADA, a Precision-Guided Dosing Test Supporting Adalimumab Treatment Optimization, Demonstrates Strong Clinical Utility in New Study
News & Events PredictrPK® ADA, [...]
Prometheus Laboratories Presents Novel Data on Precision-Guided Care in IBD at DDW® 2025
News & Events Prometheus Laboratories [...]
Prometheus Laboratories Launches First Pre-Therapy Test to Predict Likelihood of Biologic Response
News & Events Prometheus Laboratories [...]